As market factors drive the rapid growth of decentralized clinical trials, organizations should embrace risk-based quality management to evaluate the new dimensions of risk and ensure effective oversight of disparate data sources, writes John Hall.
John Hall
Advertisement
SVP, EMEA & APAC, CluePoints
Articles by John Hall
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Comparing OpenAI and Mistral on Clinical Trial Matching
2
From Complexity to Endpoint Meaningfulness: Addressing Key Neuroscience Trial Challenges with eCOA
3
Why Outdated Perceptions of APAC Clinical Trial Sites Persist Among Smaller Biotechs
4
Embedding AI Across the Clinical Operating Model: Q&A with Rajneesh Patil, Syneos Health
5